Company Immune Therapeutics, Inc. Other OTC
Equities
IMUN
US45252A1079
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Noreen Griffin
FOU | Founder | 71 | 02/93/02 |
Glen Farmer
DFI | Director of Finance/CFO | 55 | 02/22/02 |
Robert Wilson
BRD | Director/Board Member | 51 | 31/22/31 |
Cynthia Douglas
SEC | Corporate Secretary | 51 | 01/22/01 |
Comptroller/Controller/Auditor | 68 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Wilson
BRD | Director/Board Member | 51 | 31/22/31 |
Mary Caperton
BRD | Director/Board Member | 62 | 24/23/24 |
Roger Suro
BRD | Director/Board Member | 50 | 08/11 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 83,711,316 | 26,075,468 ( 31.15 %) | 0 | 31.15 % |
Company contact information
![address Immune Therapeutics, Inc.(IMUN)](https://cdn.zonebourse.com/static/address/19157246.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+15.19% | 121B | |
+19.91% | 114B | |
+8.24% | 23.61B | |
-19.80% | 20.43B | |
-16.19% | 16.55B | |
-13.45% | 16.45B | |
-44.35% | 15.59B | |
+66.67% | 15.19B | |
+2.13% | 13.54B |